Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.
Products, services, technology
- ADX71149 (mGlu2 PAM)
- Dipraglurant (mGlu5 NAM)
- GABAB PAM - SUD
- GABAB PAM - Chronic cough, pain & CMT1A
- mGlu7 NAM - Stress-related disorders – PTSD
- mGlu2 NAM - Mild neurocognitive disorders & depression
- M4 PAM - Schizophrenia
- mGlu4 PAM - Parkinson’s
- mGlu3 PAM - Neurodegenerative disorders
- http://www.addextherapeutics.com
- +41 22 884 15 55
- info@addexpharma.com
- Tim Dyer